Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 44Neoplasms, Plasma Cell 10Neoplasms 3Vomiting 2Recurrence 2Lung Neoplasms 2Prostatic Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Nausea 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Kidney Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Disease 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Rituximab 66Cyclophosphamide 46Vincristine 40Doxorubicin 40Prednisone 35Etoposide 19Radiotherapy 14Gemcitabine 13Peripheral Blood Stem Cell Transplantation 12Filgrastim 12Cytarabine 12Lenalidomide 11Carmustine 10VAP-cyclo protocol 9Prednisolone 9Oxaliplatin 9Melphalan 9Methotrexate 7Ifosfamide 7Mitoxantrone 6Bleomycin 6polatuzumab vedotin 5R-CHOP protocol 4Methylprednisolone 4Injections 4Granulocyte Colony-Stimulating Factor 4Cyclosporine 4Cisplatin 4Carboplatin 4pegfilgrastim 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large B-Cell, Diffuse × Thalidomide × Clear all
NCT03016000 2017-07-28

Thalidomide Maintenance Treatment in DLBCL

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
226 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡